Stimulating healthy tissue regeneration by targeting the 5-HT 2B receptor in chronic liver disease

Mohammad Ebrahimkhani, Fiona Oakley, Lindsay B. Murphy, Jelena Mann, Anna Moles, Maria J. Perugorria, Elizabeth Ellis, Anne F. Lakey, Alastair D. Burt, Angela Douglass, Matthew C. Wright, Steven A. White, Fabrice Jaffré, Luc Maroteaux, Derek A. Mann

Research output: Contribution to journalArticle

110 Citations (Scopus)

Abstract

Tissue homeostasis requires an effective, limited wound-healing response to injury. In chronic disease, failure to regenerate parenchymal tissue leads to the replacement of lost cellular mass with a fibrotic matrix. The mechanisms that dictate the balance of cell regeneration and fibrogenesis are not well understood 1. Here we report that fibrogenic hepatic stellate cells (HSCs) in the liver are negative regulators of hepatocyte regeneration. This negative regulatory function requires stimulation of the 5-hydroxytryptamine 2B receptor (5-HT 2B) on HSCs by serotonin, which activates expression of transforming growth factor β1 (TGF-β1), a powerful suppressor of hepatocyte proliferation, through signaling by mitogen-activated protein kinase 1 (ERK) and the transcription factor JunD. Selective antagonism of 5-HT 2B enhanced hepatocyte growth in models of acute and chronic liver injury. We also observed similar effects in mice lacking 5-HT 2B or JunD or upon selective depletion of HSCs in wild-type mice. Antagonism of 5-HT 2B attenuated fibrogenesis and improved liver function in disease models in which fibrosis was pre-established and progressive. Pharmacological targeting of 5-HT 2B is clinically safe in humans and may be therapeutic in chronic liver disease.

Original languageEnglish (US)
Pages (from-to)1668-1673
Number of pages6
JournalNature Medicine
Volume17
Issue number12
DOIs
StatePublished - Dec 2011
Externally publishedYes

Fingerprint

Receptor, Serotonin, 5-HT2B
Tissue regeneration
Liver
Liver Diseases
Regeneration
Chronic Disease
Hepatic Stellate Cells
Hepatocytes
Tissue homeostasis
Mitogen-Activated Protein Kinase 1
Wounds and Injuries
Transforming Growth Factors
Wound Healing
Serotonin
Homeostasis
Fibrosis
Transcription Factors
Pharmacology
Tissue
Growth

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Ebrahimkhani, M., Oakley, F., Murphy, L. B., Mann, J., Moles, A., Perugorria, M. J., ... Mann, D. A. (2011). Stimulating healthy tissue regeneration by targeting the 5-HT 2B receptor in chronic liver disease. Nature Medicine, 17(12), 1668-1673. https://doi.org/10.1038/nm.2490

Stimulating healthy tissue regeneration by targeting the 5-HT 2B receptor in chronic liver disease. / Ebrahimkhani, Mohammad; Oakley, Fiona; Murphy, Lindsay B.; Mann, Jelena; Moles, Anna; Perugorria, Maria J.; Ellis, Elizabeth; Lakey, Anne F.; Burt, Alastair D.; Douglass, Angela; Wright, Matthew C.; White, Steven A.; Jaffré, Fabrice; Maroteaux, Luc; Mann, Derek A.

In: Nature Medicine, Vol. 17, No. 12, 12.2011, p. 1668-1673.

Research output: Contribution to journalArticle

Ebrahimkhani, M, Oakley, F, Murphy, LB, Mann, J, Moles, A, Perugorria, MJ, Ellis, E, Lakey, AF, Burt, AD, Douglass, A, Wright, MC, White, SA, Jaffré, F, Maroteaux, L & Mann, DA 2011, 'Stimulating healthy tissue regeneration by targeting the 5-HT 2B receptor in chronic liver disease', Nature Medicine, vol. 17, no. 12, pp. 1668-1673. https://doi.org/10.1038/nm.2490
Ebrahimkhani, Mohammad ; Oakley, Fiona ; Murphy, Lindsay B. ; Mann, Jelena ; Moles, Anna ; Perugorria, Maria J. ; Ellis, Elizabeth ; Lakey, Anne F. ; Burt, Alastair D. ; Douglass, Angela ; Wright, Matthew C. ; White, Steven A. ; Jaffré, Fabrice ; Maroteaux, Luc ; Mann, Derek A. / Stimulating healthy tissue regeneration by targeting the 5-HT 2B receptor in chronic liver disease. In: Nature Medicine. 2011 ; Vol. 17, No. 12. pp. 1668-1673.
@article{d9d12ae544c94b9198e8ef1a0a71a254,
title = "Stimulating healthy tissue regeneration by targeting the 5-HT 2B receptor in chronic liver disease",
abstract = "Tissue homeostasis requires an effective, limited wound-healing response to injury. In chronic disease, failure to regenerate parenchymal tissue leads to the replacement of lost cellular mass with a fibrotic matrix. The mechanisms that dictate the balance of cell regeneration and fibrogenesis are not well understood 1. Here we report that fibrogenic hepatic stellate cells (HSCs) in the liver are negative regulators of hepatocyte regeneration. This negative regulatory function requires stimulation of the 5-hydroxytryptamine 2B receptor (5-HT 2B) on HSCs by serotonin, which activates expression of transforming growth factor β1 (TGF-β1), a powerful suppressor of hepatocyte proliferation, through signaling by mitogen-activated protein kinase 1 (ERK) and the transcription factor JunD. Selective antagonism of 5-HT 2B enhanced hepatocyte growth in models of acute and chronic liver injury. We also observed similar effects in mice lacking 5-HT 2B or JunD or upon selective depletion of HSCs in wild-type mice. Antagonism of 5-HT 2B attenuated fibrogenesis and improved liver function in disease models in which fibrosis was pre-established and progressive. Pharmacological targeting of 5-HT 2B is clinically safe in humans and may be therapeutic in chronic liver disease.",
author = "Mohammad Ebrahimkhani and Fiona Oakley and Murphy, {Lindsay B.} and Jelena Mann and Anna Moles and Perugorria, {Maria J.} and Elizabeth Ellis and Lakey, {Anne F.} and Burt, {Alastair D.} and Angela Douglass and Wright, {Matthew C.} and White, {Steven A.} and Fabrice Jaffr{\'e} and Luc Maroteaux and Mann, {Derek A.}",
year = "2011",
month = "12",
doi = "10.1038/nm.2490",
language = "English (US)",
volume = "17",
pages = "1668--1673",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Stimulating healthy tissue regeneration by targeting the 5-HT 2B receptor in chronic liver disease

AU - Ebrahimkhani, Mohammad

AU - Oakley, Fiona

AU - Murphy, Lindsay B.

AU - Mann, Jelena

AU - Moles, Anna

AU - Perugorria, Maria J.

AU - Ellis, Elizabeth

AU - Lakey, Anne F.

AU - Burt, Alastair D.

AU - Douglass, Angela

AU - Wright, Matthew C.

AU - White, Steven A.

AU - Jaffré, Fabrice

AU - Maroteaux, Luc

AU - Mann, Derek A.

PY - 2011/12

Y1 - 2011/12

N2 - Tissue homeostasis requires an effective, limited wound-healing response to injury. In chronic disease, failure to regenerate parenchymal tissue leads to the replacement of lost cellular mass with a fibrotic matrix. The mechanisms that dictate the balance of cell regeneration and fibrogenesis are not well understood 1. Here we report that fibrogenic hepatic stellate cells (HSCs) in the liver are negative regulators of hepatocyte regeneration. This negative regulatory function requires stimulation of the 5-hydroxytryptamine 2B receptor (5-HT 2B) on HSCs by serotonin, which activates expression of transforming growth factor β1 (TGF-β1), a powerful suppressor of hepatocyte proliferation, through signaling by mitogen-activated protein kinase 1 (ERK) and the transcription factor JunD. Selective antagonism of 5-HT 2B enhanced hepatocyte growth in models of acute and chronic liver injury. We also observed similar effects in mice lacking 5-HT 2B or JunD or upon selective depletion of HSCs in wild-type mice. Antagonism of 5-HT 2B attenuated fibrogenesis and improved liver function in disease models in which fibrosis was pre-established and progressive. Pharmacological targeting of 5-HT 2B is clinically safe in humans and may be therapeutic in chronic liver disease.

AB - Tissue homeostasis requires an effective, limited wound-healing response to injury. In chronic disease, failure to regenerate parenchymal tissue leads to the replacement of lost cellular mass with a fibrotic matrix. The mechanisms that dictate the balance of cell regeneration and fibrogenesis are not well understood 1. Here we report that fibrogenic hepatic stellate cells (HSCs) in the liver are negative regulators of hepatocyte regeneration. This negative regulatory function requires stimulation of the 5-hydroxytryptamine 2B receptor (5-HT 2B) on HSCs by serotonin, which activates expression of transforming growth factor β1 (TGF-β1), a powerful suppressor of hepatocyte proliferation, through signaling by mitogen-activated protein kinase 1 (ERK) and the transcription factor JunD. Selective antagonism of 5-HT 2B enhanced hepatocyte growth in models of acute and chronic liver injury. We also observed similar effects in mice lacking 5-HT 2B or JunD or upon selective depletion of HSCs in wild-type mice. Antagonism of 5-HT 2B attenuated fibrogenesis and improved liver function in disease models in which fibrosis was pre-established and progressive. Pharmacological targeting of 5-HT 2B is clinically safe in humans and may be therapeutic in chronic liver disease.

UR - http://www.scopus.com/inward/record.url?scp=84856094934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856094934&partnerID=8YFLogxK

U2 - 10.1038/nm.2490

DO - 10.1038/nm.2490

M3 - Article

C2 - 22120177

AN - SCOPUS:84856094934

VL - 17

SP - 1668

EP - 1673

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 12

ER -